Clostridium symbiosum
Selected indexed studies
- BCAA-producing Clostridium symbiosum promotes colorectal tumorigenesis through the modulation of host cholesterol metabolism. (Cell Host Microbe, 2024) [PMID:39106870]
- Gut Microbiota-Derived Short-Chain Fatty Acids Promote Poststroke Recovery in Aged Mice. (Circ Res, 2020) [PMID:32354259]
- Gut pathogen Clostridium symbiosum rewires macrophage succinylation to drive enteric neuron loss in inflammatory bowel disease. (Cell Host Microbe, 2026) [PMID:41881016]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Gut Microbiota-Derived Short-Chain Fatty Acids Promote Poststroke Recovery in Aged Mice. (2020) pubmed
- BCAA-producing Clostridium symbiosum promotes colorectal tumorigenesis through the modulation of host cholesterol metabolism. (2024) pubmed
- Gut pathogen Clostridium symbiosum rewires macrophage succinylation to drive enteric neuron loss in inflammatory bowel disease. (2026) pubmed
- Clostridium symbiosum: A novel pathogen causing central nervous system infections in encephalitis patients. (2024) pubmed
- A toolbox for genetic manipulation in intestinal Clostridium symbiosum. (2024) pubmed
- Gut-derived succinic acid potentiates high-altitude-related spermatogenesis dysfunction. (2026) pubmed
- Meta-Analysis of Altered Gut Microbiota Reveals Microbial and Metabolic Biomarkers for Colorectal Cancer. (2022) pubmed
- Consistent signatures in the human gut microbiome of old- and young-onset colorectal cancer. (2024) pubmed
- Lactococcus lactis and Bifidobacterium longum attenuate Clostridioides difficile- or Clostridium symbiosum-induced colitis and depression/anxiety-like behavior in male mice. (2025) pubmed
- Gut microbiome and metabolome signatures in liver cirrhosis-related complications. (2024) pubmed